Condition: Intraoperative Hypotension · Ciprofol · Renin-angiotensin System Inhibitors · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
The prevention of intraoperative hypotension could reduce postoperative organ injury and mortality, particularly in elderly patients receiving long-term renin-angiotensin system inhibitors. Previous meta-analyses suggest that ciprofol, a novel intravenous anesthetic agent, may provide improved hemodynamic stability compared to propofol; however, its precise effects on perioperative hemodynamics remain unclear. The study will assess whether ciprofol improves perioperative hemodynamic stability in elderly patients receiving renin-angiotensin system inhibitors.
This description comes directly from the study's public registry record.
Min Yan · 0571-87783759 · zryanmin@zju.edu.cn
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Zhejiang University anesthesiology department | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06952608